Dr Reddy’s Laboratories has succeeded in developing a generic version of Pfizer’s Lipitor, the world's largest selling drug which has sales of over $10 billion. With this, the Indian drug maker has joined the club of only a few generic companies hoping to grab a share of the cholesterol-lowering drug's market when its patent expires from next year. The only Indian company in the club so far has been Ranbaxy.
Dr Reddy's Laboratories and its
The gains for Dr Reddy's might not be as big as that of Ranbaxy, which was the first company to develop a generic for Lipitor and held a six-month exclusive sales right in the US market upon patent expiry by next year. Dr Reddy's is not going to launch its generic before 2013. By that time, there will be many players in the market.
Dr Reddy's, the second largest domestic drug maker after Ranbaxy in terms of sales, is planning to launch six to seven new generics in the
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1808.50 |
Dr. Reddys Lab | 1342.45 |
Cipla | 1472.45 |
Lupin | 2147.55 |
Zydus Lifesciences | 973.90 |
View more.. |